TY - JOUR
T1 - Early onset epileptic encephalopathy caused by de novo SCN8A mutations
AU - Ohba, Chihiro
AU - Kato, Mitsuhiro
AU - Takahashi, Satoru
AU - Lerman-Sagie, Tally
AU - Lev, Dorit
AU - Terashima, Hiroshi
AU - Kubota, Masaya
AU - Kawawaki, Hisashi
AU - Matsufuji, Mayumi
AU - Kojima, Yasuko
AU - Tateno, Akihiko
AU - Goldberg-Stern, Hadassa
AU - Straussberg, Rachel
AU - Marom, Dafna
AU - Leshinsky-Silver, Esther
AU - Nakashima, Mitsuko
AU - Nishiyama, Kiyomi
AU - Tsurusaki, Yoshinori
AU - Miyake, Noriko
AU - Tanaka, Fumiaki
AU - Matsumoto, Naomichi
AU - Saitsu, Hirotomo
PY - 2014/7
Y1 - 2014/7
N2 - Objective De novo SCN8A mutations have been reported in patients with epileptic encephalopathy. Herein we report seven patients with de novo heterozygous SCN8A mutations, which were found in our comprehensive genetic analysis (target capture or whole-exome sequencing) for early onset epileptic encephalopathies (EOEEs). Methods A total of 163 patients with EOEEs without mutations in known genes, including 6 with malignant migrating partial seizures in infancy (MMPSI), and 60 with unclassified EOEEs, were analyzed by target capture (28 samples) or whole-exome sequencing (135 samples). Results We identified de novo SCN8A mutations in 7 patients: 6 of 60 unclassified EOEEs (10.0%), and one of 6 MMPSI cases (16.7%). The mutations were scattered through the entire gene: four mutations were located in linker regions, two in the fourth transmembrane segments, and one in the C-terminal domain. The type of the initial seizures was variable including generalized tonic-clonic, atypical absence, partial, apneic attack, febrile convulsion, and loss of tone and consciousness. Onset of seizures was during the neonatal period in two patients, and between 3 and 7 months of age in five patients. Brain magnetic resonance imaging (MRI) showed cerebellar and cerebral atrophy in one and six patients, respectively. All patients with SCN8A missense mutations showed initially uncontrollable seizures by any drugs, but eventually one was seizure-free and three were controlled at the last examination. All patients showed developmental delay or regression in infancy, resulting in severe intellectual disability. Significance Our data reveal that SCN8A mutations can cause variable phenotypes, most of which can be diagnosed as unclassified EOEEs, and rarely as MMPSI. Together with previous reports, our study further indicates that genetic testing of SCN8A should be considered in children with unclassified severe epilepsy. A PowerPoint slide summarizing this article is available for download in the Supporting Information section here.
AB - Objective De novo SCN8A mutations have been reported in patients with epileptic encephalopathy. Herein we report seven patients with de novo heterozygous SCN8A mutations, which were found in our comprehensive genetic analysis (target capture or whole-exome sequencing) for early onset epileptic encephalopathies (EOEEs). Methods A total of 163 patients with EOEEs without mutations in known genes, including 6 with malignant migrating partial seizures in infancy (MMPSI), and 60 with unclassified EOEEs, were analyzed by target capture (28 samples) or whole-exome sequencing (135 samples). Results We identified de novo SCN8A mutations in 7 patients: 6 of 60 unclassified EOEEs (10.0%), and one of 6 MMPSI cases (16.7%). The mutations were scattered through the entire gene: four mutations were located in linker regions, two in the fourth transmembrane segments, and one in the C-terminal domain. The type of the initial seizures was variable including generalized tonic-clonic, atypical absence, partial, apneic attack, febrile convulsion, and loss of tone and consciousness. Onset of seizures was during the neonatal period in two patients, and between 3 and 7 months of age in five patients. Brain magnetic resonance imaging (MRI) showed cerebellar and cerebral atrophy in one and six patients, respectively. All patients with SCN8A missense mutations showed initially uncontrollable seizures by any drugs, but eventually one was seizure-free and three were controlled at the last examination. All patients showed developmental delay or regression in infancy, resulting in severe intellectual disability. Significance Our data reveal that SCN8A mutations can cause variable phenotypes, most of which can be diagnosed as unclassified EOEEs, and rarely as MMPSI. Together with previous reports, our study further indicates that genetic testing of SCN8A should be considered in children with unclassified severe epilepsy. A PowerPoint slide summarizing this article is available for download in the Supporting Information section here.
KW - De novo mutation
KW - Early onset epileptic encephalopathies
KW - SCN8A
UR - http://www.scopus.com/inward/record.url?scp=84904392275&partnerID=8YFLogxK
U2 - 10.1111/epi.12668
DO - 10.1111/epi.12668
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 24888894
AN - SCOPUS:84904392275
SN - 0013-9580
VL - 55
SP - 994
EP - 1000
JO - Epilepsia
JF - Epilepsia
IS - 7
ER -